Correlation of interleukin-6 with Epstein–Barr virus levels in COVID-19
Open Access
- 23 November 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-3
- https://doi.org/10.1186/s13054-020-03384-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- COVID-19: consider cytokine storm syndromes and immunosuppressionThe Lancet, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Epidemiology of Multiple Herpes Viremia in Previously Immunocompetent Patients With Septic ShockClinical Infectious Diseases, 2017
- Antibiotic-Induced Rash in Patients With Infectious MononucleosisAnnals of Pharmacotherapy, 2016
- EBV-encoded dUTPase induces immune dysregulation: Implications for the pathophysiology of EBV-associated diseaseVirology, 2005
- Rash Associated with Piperacillin/Tazobactam Administration in Infectious MononucleosisAnnals of Pharmacotherapy, 2004